Medtronic Announces the Availability of the CD HORIZON® LEGACY™ 4.5 Spinal System with G4 Technology

MEMPHIS, Tenn. – July 27, 2006 – Medtronic, Inc. (NYSE: MDT) today announced the U.S. availability of the CD HORIZON® LEGACY™ 4.5 Spinal System with G4 Technology. The CD HORIZON LEGACY 4.5 Spinal System combines the clinically proven deformity reduction capabilities of the CD HORIZON LEGACY 5.5 and 6.35 Spinal Systems with a lower profile implant design for better patient matching.

The CD HORIZON LEGACY 4.5 Spinal System is designed to treat smaller patients with spinal deformities using a best-in-class posterior instrumentation solution. The system, with a 4.5mm surgical rod implant, combines the proper balance of flexibility, strength and profile for smaller stature patients while the screws, available in multiple diameters, provide surgeons with a more precise fit in various anatomies.

The CD HORIZON LEGACY 4.5 Spinal System features the G4 closure technology - a reverse-angle set screw designed to thread more easily and increase construct strength while minimizing the implant’s head size.

Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.

About Medtronic’s Spinal Business
Medtronic’s spinal business, based in Memphis, Tenn., is the global leader in today’s spine market and is committed to advancing the treatment of spinal conditions. Medtronic’s spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art products and technologies for neurological, orthopedic and spinal conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronicspinal.com and its patient-education Web sites, www.back.com, www.iscoliosis.com, www.maturespine.com and www.necksurgery.com.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

-end-

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.

Contact Information

Bert Kelly

Public Relations Communications Manager

Medtronic, Inc.

Contact via E-mail